AIM: To evaluate the completion rate and diagnostic yield of the PillCam SB2-ex in comparison to the PillCam SB2. METHODS: Two hundred cases using the 8-h PillCam SB2 were retrospectively compared to 200 cases using the 12 h PillCam SB2-ex at a tertiary academic center. Endoscopically placed capsules were excluded from the study. Demographic information, indications for capsule endoscopy, capsule type, study length, completion of exam, clinically significant findings, timestamp of most distant finding, and significant findings beyond 8 h were recorded. RESULTS: The 8 and 12 h capsule groups were well matched respectively for both age (70.90 ± 14.19 vs 71.93 ± 13.80, P = 0.46) and gender (45.5% vs 48% male, P = 0.69). The most common indications for the procedure in both groups were anemia and obscure gastrointestinal bleeding. PillCam SB2-ex had a significantly higher completion rate than PillCam SB2 (88% vs 79.5%, P = 0.03). Overall, the diagnostic yield was greater for the 8 h capsule (48.5% for SB2 vs 35% for SB2-ex, P = 0.01). In 4/70 (5.7%) of abnormal SB2-ex exams the clinically significant finding was noted in the small bowel beyond the 8 h mark. CONCLUSION: In our study, we found the PillCam SB2-ex to have a significantly increased completion rate, though without any improvement in diagnostic yield compared to the PillCam SB2.
AIM: To evaluate the completion rate and diagnostic yield of the PillCam SB2-ex in comparison to the PillCam SB2. METHODS: Two hundred cases using the 8-h PillCam SB2 were retrospectively compared to 200 cases using the 12 h PillCam SB2-ex at a tertiary academic center. Endoscopically placed capsules were excluded from the study. Demographic information, indications for capsule endoscopy, capsule type, study length, completion of exam, clinically significant findings, timestamp of most distant finding, and significant findings beyond 8 h were recorded. RESULTS: The 8 and 12 h capsule groups were well matched respectively for both age (70.90 ± 14.19 vs 71.93 ± 13.80, P = 0.46) and gender (45.5% vs 48% male, P = 0.69). The most common indications for the procedure in both groups were anemia and obscure gastrointestinal bleeding. PillCam SB2-ex had a significantly higher completion rate than PillCam SB2 (88% vs 79.5%, P = 0.03). Overall, the diagnostic yield was greater for the 8 h capsule (48.5% for SB2 vs 35% for SB2-ex, P = 0.01). In 4/70 (5.7%) of abnormal SB2-ex exams the clinically significant finding was noted in the small bowel beyond the 8 h mark. CONCLUSION: In our study, we found the PillCam SB2-ex to have a significantly increased completion rate, though without any improvement in diagnostic yield compared to the PillCam SB2.
Authors: Anastasios Koulaouzidis; Andry Giannakou; Diana E Yung; Konstantinos J Dabos; John N Plevris Journal: Curr Med Res Opin Date: 2013-07-11 Impact factor: 2.580
Authors: Elisabeth Mathus-Vliegen; Maria Pellisé; Denis Heresbach; Wolfgang Fischbach; Tricia Dixon; Jonathan Belsey; Fabrizio Parente; Ricardo Rio-Tinto; Alistair Brown; Ervin Toth; Cristiano Crosta; Peter Layer; Owen Epstein; Christian Boustiere Journal: Curr Med Res Opin Date: 2013-06-04 Impact factor: 2.580
Authors: Sietze T van Turenhout; Maarten A J M Jacobs; Stijn J van Weyenberg; Erik Herdes; Fred Stam; Chris J J Mulder; Gerd Bouma Journal: J Gastrointestin Liver Dis Date: 2010-06 Impact factor: 2.008
Authors: David R Cave; David E Fleischer; Jonathan A Leighton; Douglas O Faigel; Russell I Heigh; Virender K Sharma; Christopher J Gostout; Elizabeth Rajan; Klaus Mergener; Anne Foley; Michael Lee; Kanishka Bhattacharya Journal: Gastrointest Endosc Date: 2008-04-14 Impact factor: 9.427
Authors: Sara Monteiro; Francisca Dias de Castro; Pedro Boal Carvalho; Maria João Moreira; Bruno Rosa; José Cotter Journal: World J Gastroenterol Date: 2016-03-14 Impact factor: 5.742
Authors: Gerard Cummins; Benjamin F Cox; Gastone Ciuti; Thineskrishna Anbarasan; Marc P Y Desmulliez; Sandy Cochran; Robert Steele; John N Plevris; Anastasios Koulaouzidis Journal: Nat Rev Gastroenterol Hepatol Date: 2019-07 Impact factor: 46.802